pharmacogenomics
BostonGene Partners with NEC to Offer Tumor Portrait Tests Internationally
NEC, an investor in BostonGene, will initially help provide Tumor Portrait to hospitals in Japan using its healthcare and life science network.
The new partners seek to close the information loop by including providers, payors, and patients in biomarker-guided cancer therapy decisions.
Wales to Routinely Screen Cancer Patients With Yourgene Elucigene Test
Yourgene will provide its Elucigene DPYD tests to screen approximately 200 patients each month for the next year.
Cancer AI Startup Nucleai Raises $6.5M in Series A Financing
The initial investment is led by Debiopharm, which will collaborate with the Israeli startup to accelerate discovery of biomarkers for oncology drug response.
With EMR upgrades, Penn and Rush now have structured genomic data informing clinical decision support in their precision oncology programs, but much work remains.